These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 8925935

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Activation of HIV-1 long terminal repeat transcription and virus replication via NF-kappaB-dependent and -independent pathways by potent phosphotyrosine phosphatase inhibitors, the peroxovanadium compounds.
    Barbeau B, Bernier R, Dumais N, Briand G, Olivier M, Faure R, Posner BI, Tremblay M.
    J Biol Chem; 1997 May 16; 272(20):12968-77. PubMed ID: 9148903
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. TNF-alpha-mediated activation of HIV-1 LTR in monocytoid cells by mycobacteria.
    Kitaura H, Ohara N, Kobayashi K, Yamada T.
    FEMS Immunol Med Microbiol; 2001 Aug 16; 31(2):97-103. PubMed ID: 11549416
    [Abstract] [Full Text] [Related]

  • 7. Lack of responsiveness of a nuclear factor-kappaB-regulated promoter to transactivation by human immunodeficiency virus 1 Tat in HeLa cells.
    Kelly GD, Morris CB, Offermann MK.
    Virology; 1999 Oct 10; 263(1):128-38. PubMed ID: 10544088
    [Abstract] [Full Text] [Related]

  • 8. Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.
    Wires ES, Alvarez D, Dobrowolski C, Wang Y, Morales M, Karn J, Harvey BK.
    J Neurovirol; 2012 Oct 10; 18(5):400-10. PubMed ID: 22618514
    [Abstract] [Full Text] [Related]

  • 9. Synergistic activation of human immunodeficiency virus type 1 promoter activity by NF-kappaB and inhibitors of deacetylases: potential perspectives for the development of therapeutic strategies.
    Quivy V, Adam E, Collette Y, Demonte D, Chariot A, Vanhulle C, Berkhout B, Castellano R, de Launoit Y, Burny A, Piette J, Bours V, Van Lint C.
    J Virol; 2002 Nov 10; 76(21):11091-103. PubMed ID: 12368351
    [Abstract] [Full Text] [Related]

  • 10. N-acetyl-L-cysteine-induced up-regulation of HIV-1 gene expression in monocyte-derived macrophages correlates with increased NF-kappaB DNA binding activity.
    Nottet HS, Moelans II, de Vos NM, de Graaf L, Visser MR, Verhoef J.
    J Leukoc Biol; 1997 Jan 10; 61(1):33-9. PubMed ID: 9000534
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Poly (ADP-ribose) polymerase is involved in PMA-induced activation of HIV-1 in U1 cells by modulating the LTR function.
    Kameoka M, Tanaka Y, Ota K, Itaya A, Yoshihara K.
    Biochem Biophys Res Commun; 1999 Aug 19; 262(1):285-9. PubMed ID: 10448106
    [Abstract] [Full Text] [Related]

  • 13. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
    Doerre S, Sista P, Sun SC, Ballard DW, Greene WC.
    Proc Natl Acad Sci U S A; 1993 Feb 01; 90(3):1023-7. PubMed ID: 8430069
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of human immunodeficiency virus type 1 replication by a bioavailable serine/threonine kinase inhibitor, fasudil hydrochloride.
    Sato T, Asamitsu K, Yang JP, Takahashi N, Tetsuka T, Yoneyama A, Kanagawa A, Okamoto T.
    AIDS Res Hum Retroviruses; 1998 Mar 01; 14(4):293-8. PubMed ID: 9519889
    [Abstract] [Full Text] [Related]

  • 15. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ, Phillips D, Millhouse S, Conner J, Hogan T, Ross HL, Wigdahl B.
    Virology; 2000 Sep 01; 274(2):262-77. PubMed ID: 10964770
    [Abstract] [Full Text] [Related]

  • 16. An NF-kappaB site in the 5'-untranslated leader region of the human immunodeficiency virus type 1 enhances the viral expression in response to NF-kappaB-activating stimuli.
    Mallardo M, Dragonetti E, Baldassarre F, Ambrosino C, Scala G, Quinto I.
    J Biol Chem; 1996 Aug 23; 271(34):20820-7. PubMed ID: 8702837
    [Abstract] [Full Text] [Related]

  • 17. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
    Biswas DK, Ahlers CM, Dezube BJ, Pardee AB.
    Proc Natl Acad Sci U S A; 1993 Dec 01; 90(23):11044-8. PubMed ID: 8248210
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of replication of reactivated human immunodeficiency virus type 1 (HIV-1) in latently infected U1 cells transduced with an HIV-1 long terminal repeat-driven PKR cDNA construct.
    Muto NF, Martinand-Mari C, Adelson ME, Suhadolnik RJ.
    J Virol; 1999 Nov 01; 73(11):9021-8. PubMed ID: 10516008
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.